<?xml version="1.0"?>
<rss version="2.0"><channel><title>The Hearing Industry Resource: All Reuters Health Stories</title><link>http://www.hearingreview.com/reuters/</link><description></description><language>en-us</language><pubDate>Tue, 26 Aug 2008 16:10 EST</pubDate><lastBuildDate>Tue, 26 Aug 2008 16:10 EST</lastBuildDate><item><title>LV diastolic dysfunction predicts poor response to resynchronization therapy</title><link>http://www.hearingreview.com/reuters_article.asp?id=20080826clin002%2Ehtml</link><description>NEW YORK (Reuters Health) - Patients with increased left ventricular end-systolic diameter and concomitant diastolic dysfunction have a poor response to cardiac resynchronization therapy (CRT), German investigators report.</description><pubDate>Tue, 26 Aug 2008 16:10 EST</pubDate><guid isPermaLink="true">http://www.hearingreview.com/reuters_article.asp?id=20080826clin002%2Ehtml</guid></item><item><title>Postop alcohol withdrawal therapy can help head and neck cancer patients</title><link>http://www.hearingreview.com/reuters_article.asp?id=20080826clin008%2Ehtml</link><description>NEW YORK (Reuters Health) - Early recognition and treatment of alcohol withdrawal syndrome (AWS) led to improved outcome in a postoperative group of patients with head and neck cancer, researchers report in the August issue of the Archives of Otolaryngology--Head and Neck Surgery.</description><pubDate>Tue, 26 Aug 2008 16:06 EST</pubDate><guid isPermaLink="true">http://www.hearingreview.com/reuters_article.asp?id=20080826clin008%2Ehtml</guid></item><item><title>Two MS patients treated with Tysabri recovering from PML</title><link>http://www.hearingreview.com/reuters_article.asp?id=20080826clin012%2Ehtml</link><description>LONDON (Reuters) - Two European patients who developed progressive multifocal leukoencephalopathy (PML) after being given Biogen Idec and Elan Corp's multiple sclerosis drug Tysabri are now recovering, a researcher involved in their care said on Tuesday.</description><pubDate>Tue, 26 Aug 2008 16:04 EST</pubDate><guid isPermaLink="true">http://www.hearingreview.com/reuters_article.asp?id=20080826clin012%2Ehtml</guid></item><item><title>Allopurinol lowers blood pressure in teens with essential hypertension</title><link>http://www.hearingreview.com/reuters_article.asp?id=20080826clin004%2Ehtml</link><description>NEW YORK (Reuters Health) - The anti-gout medication allopurinol could represent an effective treatment for adolescents with stage I essential hypertension, findings from a small study suggest.</description><pubDate>Tue, 26 Aug 2008 16:00 EST</pubDate><guid isPermaLink="true">http://www.hearingreview.com/reuters_article.asp?id=20080826clin004%2Ehtml</guid></item><item><title>Eating nuts and popcorn may protect against diverticulitis</title><link>http://www.hearingreview.com/reuters_article.asp?id=20080826clin003%2Ehtml</link><description>NEW YORK (Reuters Health) - New findings from the prospective Health Professionals Follow-up Study "refute the pervasive but unproven belief" that consumption of nuts, corn, and popcorn is associated with diverticular complications, according to an article in the Journal of the American Medical Association for July 27.</description><pubDate>Tue, 26 Aug 2008 16:00 EST</pubDate><guid isPermaLink="true">http://www.hearingreview.com/reuters_article.asp?id=20080826clin003%2Ehtml</guid></item><item><title>Levonorgestrel IUD may increase breast cancer relapse risk in some patients</title><link>http://www.hearingreview.com/reuters_article.asp?id=20080826clin018%2Ehtml</link><description>NEW YORK (Reuters Health) - Women who develop breast cancer while using a levonorgestrel-releasing intrauterine device (LNG-IUD) and continue to use it may be at slightly higher risk of breast cancer recurrence following treatment, physicians in Belgium report.</description><pubDate>Tue, 26 Aug 2008 15:49 EST</pubDate><guid isPermaLink="true">http://www.hearingreview.com/reuters_article.asp?id=20080826clin018%2Ehtml</guid></item><item><title>Study supports prompt HCV therapy in HIV/HCV-coinfected patients</title><link>http://www.hearingreview.com/reuters_article.asp?id=20080826clin016%2Ehtml</link><description>NEW YORK (Reuters Health) - Patients coinfected with hepatitis C virus (HCV) and HIV often exhibit low levels of HCV neutralizing antibodies, which could contribute to a poorer outcome of HCV infection, a French study indicates.</description><pubDate>Tue, 26 Aug 2008 15:46 EST</pubDate><guid isPermaLink="true">http://www.hearingreview.com/reuters_article.asp?id=20080826clin016%2Ehtml</guid></item><item><title>Amifostine lowers risk of cisplatin-related hearing loss in children</title><link>http://www.hearingreview.com/reuters_article.asp?id=20080826clin001%2Ehtml</link><description>NEW YORK (Reuters Health) - A cytoprotective adjuvant used in cancer chemotherapy, amifostine, reduces the likelihood of ototoxicity in children undergoing cisplatin therapy for medulloblastoma, according to a study by U.S. and Australian researchers reported in the August 1 issue of the Journal of Clinical Oncology.</description><pubDate>Tue, 26 Aug 2008 15:44 EST</pubDate><guid isPermaLink="true">http://www.hearingreview.com/reuters_article.asp?id=20080826clin001%2Ehtml</guid></item><item><title>Pegylated liposomal doxorubicin prevents relapse of HIV-related Kaposi sarcoma</title><link>http://www.hearingreview.com/reuters_article.asp?id=20080826clin010%2Ehtml</link><description>NEW YORK (Reuters Health) - Among HIV-infected patients treated with pegylated liposomal doxorubicin for Kaposi sarcoma (KS), relapse rates are low, according to a report in the August 1st issue of Clinical Infectious Diseases.</description><pubDate>Tue, 26 Aug 2008 15:42 EST</pubDate><guid isPermaLink="true">http://www.hearingreview.com/reuters_article.asp?id=20080826clin010%2Ehtml</guid></item><item><title>REFILE:  Radial approach to percutaneous coronary intervention may be best</title><link>http://www.hearingreview.com/reuters_article.asp?id=20080826clin007%2Ehtml</link><description>NEW YORK (Reuters Health) - Although less than 2% of percutaneous coronary interventions (PCIs) are performed using a radial artery approach, this method carries a procedural success rate similar to that of the femoral approach, but is less risky, new research indicates.</description><pubDate>Tue, 26 Aug 2008 15:31 EST</pubDate><guid isPermaLink="true">http://www.hearingreview.com/reuters_article.asp?id=20080826clin007%2Ehtml</guid></item><item><title>Effective treatment of HIV in children may provoke asthma</title><link>http://www.hearingreview.com/reuters_article.asp?id=20080826clin009%2Ehtml</link><description>NEW YORK (Reuters Health) - Immune reconstitution in HIV-infected children treated with highly active antiretroviral therapy (HAART) appears to increase their risk of developing asthma, according to data from the prospective Women and Infants Transmission Study.</description><pubDate>Tue, 26 Aug 2008 14:22 EST</pubDate><guid isPermaLink="true">http://www.hearingreview.com/reuters_article.asp?id=20080826clin009%2Ehtml</guid></item><item><title>Improvements with different amblyopia treatments are similar and sustained</title><link>http://www.hearingreview.com/reuters_article.asp?id=20080826clin013%2Ehtml</link><description>NEW YORK (Reuters Health) - Atropine and patching are comparable for the treatment of moderate amblyopia in young children, a study indicates, and the improvement of the amblyopic eye is maintained at age 10 years.</description><pubDate>Tue, 26 Aug 2008 13:30 EST</pubDate><guid isPermaLink="true">http://www.hearingreview.com/reuters_article.asp?id=20080826clin013%2Ehtml</guid></item><item><title>Gait dysfunction common in mild cognitive impairment</title><link>http://www.hearingreview.com/reuters_article.asp?id=20080826clin014%2Ehtml</link><description>NEW YORK (Reuters Health) - Older patients with amnestic or non-amnestic subtypes of mild cognitive impairment often exhibit gait dysfunction, according to findings published in the July issue of the Journal of the American Geriatrics Society.</description><pubDate>Tue, 26 Aug 2008 12:18 EST</pubDate><guid isPermaLink="true">http://www.hearingreview.com/reuters_article.asp?id=20080826clin014%2Ehtml</guid></item><item><title>Vaccine cures dangerous yeast infections in mice</title><link>http://www.hearingreview.com/reuters_article.asp?id=20080826inds010%2Ehtml</link><description>CHICAGO (Reuters) - A vaccine helped mice fight off a life-threatening type of yeast infection, U.S. researchers said on Monday in a finding that holds promise for preventing this severe condition as well as pesky vaginal infections.</description><pubDate>Tue, 26 Aug 2008 11:00 EST</pubDate><guid isPermaLink="true">http://www.hearingreview.com/reuters_article.asp?id=20080826inds010%2Ehtml</guid></item><item><title>Primary Health year profit little changed</title><link>http://www.hearingreview.com/reuters_article.asp?id=20080826manc002%2Ehtml</link><description>MELBOURNE (Reuters) - Australian medical centre operator Primary Health Care Ltd reported little change in full-year operating profit on Tuesday, with underlying growth offsetting the costs of its takeover of rival Symbion Health.</description><pubDate>Tue, 26 Aug 2008 10:01 EST</pubDate><guid isPermaLink="true">http://www.hearingreview.com/reuters_article.asp?id=20080826manc002%2Ehtml</guid></item><item><title>Calif. stop-smoking campaign saved $86 bln: report</title><link>http://www.hearingreview.com/reuters_article.asp?id=20080826publ001%2Ehtml</link><description>CHICAGO (Reuters) - California's large-scale tobacco control campaign has saved $86 billion in health care costs in its first 15 years, U.S. researchers said on Monday.</description><pubDate>Tue, 26 Aug 2008 10:00 EST</pubDate><guid isPermaLink="true">http://www.hearingreview.com/reuters_article.asp?id=20080826publ001%2Ehtml</guid></item><item><title>Galapagos buys Sareum drug discovery assets</title><link>http://www.hearingreview.com/reuters_article.asp?id=20080826inds007%2Ehtml</link><description>LONDON (Reuters) - Belgium's Galapagos NV said on Tuesday it had bought the drug discovery services assets of Sareum Holdings Plc, a Cambridge-based drug discovery company, for 553,000 pounds ($1.02 million).</description><pubDate>Tue, 26 Aug 2008 09:00 EST</pubDate><guid isPermaLink="true">http://www.hearingreview.com/reuters_article.asp?id=20080826inds007%2Ehtml</guid></item><item><title>Medicare underestimated improper payments: report</title><link>http://www.hearingreview.com/reuters_article.asp?id=20080826manc001%2Ehtml</link><description>BANGALORE (Reuters) - Medicare officials had undervalued the amount of improper payments made for medical equipment in 2006 because it failed to review sufficient medical documents, according to a government report.</description><pubDate>Tue, 26 Aug 2008 09:00 EST</pubDate><guid isPermaLink="true">http://www.hearingreview.com/reuters_article.asp?id=20080826manc001%2Ehtml</guid></item><item><title>Bosnia drugs firm lifts H1 revenue, profit</title><link>http://www.hearingreview.com/reuters_article.asp?id=20080826inds005%2Ehtml</link><description>SARAJEVO (Reuters) - Bosnia's largest pharmaceutical company Bosnalijek posted net revenues of 50.6 million Bosnian marka ($38.3 million) in the first half of 2008, a 27 percent increase on the same period last year, an offical said on Tuesday.</description><pubDate>Tue, 26 Aug 2008 09:00 EST</pubDate><guid isPermaLink="true">http://www.hearingreview.com/reuters_article.asp?id=20080826inds005%2Ehtml</guid></item><item><title>Elispot assay: a promising substitute for tuberculin skin test for latent TB</title><link>http://www.hearingreview.com/reuters_article.asp?id=20080826clin005%2Ehtml</link><description>NEW YORK (Reuters Health) - Elispot, an enzyme-linked immunospot assay that detects Mycobacterium tuberculosis antigens, is a useful screening test to rule out latent tuberculosis infection in rheumatic disease patients starting treatment with a tumor necrosis factor antagonist, according to physicians in Greece.</description><pubDate>Tue, 26 Aug 2008 08:30 EST</pubDate><guid isPermaLink="true">http://www.hearingreview.com/reuters_article.asp?id=20080826clin005%2Ehtml</guid></item></channel></rss>
